Status:
UNKNOWN
Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging
Lead Sponsor:
Ping Liang
Conditions:
Focal Liver Lesions
Contrast-enhanced Ultrasound
Eligibility:
All Genders
Brief Summary
Contrast-enhanced ultrasound (CEUS) substantially improves the potential of ultrasound (US) for the identification and characterization of focal liver lesions (FLLs). Compared to contrasted-enhanced M...
Eligibility Criteria
Inclusion
- patients with a solid liver tumor visible during routine ultrasound and received CEUS.
- disease history and standard of reference of the lesions can be acquired
Exclusion
- hypersensitivity for ultrasound contrast media
- pregnant or lactating patients
- previously treated lesions or local relapse from previously treated lesions
- diffuse tumors
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04682886
Start Date
January 1 2017
End Date
December 31 2025
Last Update
December 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853